Hospital and Community Skilled Nursing Partnership for Monoclonal Antibody Treatment During the Novel Coronavirus Pandemic

Skilled nursing facilities emerged as the "canary in the coal mine" at the outset of the COVID19 pandemic. This study examines two collaborative pilots, both focused on the administration of monoclonal antibody (MAB) treatment in a skilled nursing facility (SNF), to reduce hospitalizations and deaths. The participating SNF is a 130 bed for-profit nursing home with an individual owner. The referring hospital is Baylor Scott & White Memorial Medical Center, a 635-bed non-profit tertiary hospital.